Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

 

MD Anderson receives over $21.4 million in CPRIT funding to support research and launch new core facilities

September 25, 20246 min
Research, microscope and science with black woman in laboratory for biotechnology, medical and phar.

The University of Texas MD Anderson Cancer Center was awarded nine grants totaling over $21.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of two new core facilities, faculty recruitment and groundbreaking cancer research across all areas of the institution.

 

“We are enormously appreciative of CPRIT’s support of impactful cancer research initiatives at MD Anderson,” said Peter WT Pisters, M.D., president of MD Anderson. “These new core facilities will help advance important areas of research in spatial biology and decision science, while the additional grants will advance groundbreaking work on the microbiome, cancer interception and novel therapies. This work by our world-class scientists and clinicians reflects their unwavering commitment to our goal of ending cancer.”

 

Two awards MD Anderson received, totaling over $5.9 million, support the development of two core facilities at MD Anderson. The first ever Advanced Spatial Genomics Core facility, led by Nicholas Navin, Ph.D., chair of Systems Biology, will focus on the new field of spatial genomics, which allows researchers to build an atlas of the human body by connecting images of cells and their tissue structures with genomic data while preserving their spatial arrangement. This core will connect the fields of pathology and cell biology with genomics, providing invaluable resources with the potential to dramatically improve the diagnosis and treatment of cancer and other diseases.

 

The Texas Decision Science Core facility, co-led by Robert Volk, Ph.D., and Lisa Lowenstein, Ph.D., professors of Health Services Research, is an innovative, collaborative, statewide resource for cancer researchers that combines the expertise and experience of MD Anderson’s Decision Support Lab with the network of Texas institutions participating in the UTHealth Houston Clinical Translation Hub of the UTHealth Houston Center for Clinical & Translational Sciences. The core will provide access to decision science expertise and the production of high-quality decision support tools to aid consumers, patients and clinicians in making decisions based on personal values and preferences.

 

Since its inception, CPRIT has awarded nearly $3.6 billion in grants for cancer research. MD Anderson investigators have received $645 million all told, approximately 18% of the total awards. Programs supported by CPRIT funding have brought more than 323 distinguished cancer researchers to Texas, advanced the knowledge base for cancer treatment throughout the state and provided more than 9 million cancer prevention and early detection services reaching all 254 counties in Texas.

CPRIT awards to MD Anderson include:

Individual Investigator Awards: 

  • Dietary intervention to modulate the microbiome and immune response (Jennifer McQuade, M.D., Melanoma Medical Oncology) – $1,074,727
  • Precision lung cancer interception by targeting high-risk lung nodules (Jianjun Zhang, M.D., Ph.D., Thoracic-Head and Neck Medical Oncology) ­– $1,098,945

Core Facility Awards: 

  • Advanced Spatial Genomics Core facility (Nicholas Navin, Ph.D., Systems Biology) – $2,999,993
  • The Texas Decision Science Core facility: A CPRIT population science core (Robert Volk, Ph.D., Health Services Research) – $2,995,778

High-Impact/High-Risk Research Awards: 

  • Engineering in vivo chimeric antigen receptor (CAR) macrophages for diffuse midline glioma (Wen Jiang, M.D., Ph.D., Radiation Oncology) – $250,000

Multi-investigator Awards: 

  • Innovative cell therapy approaches for hematological and solid malignancies (Sattva Neelapu, M.D., Lymphoma/Myeloma) – $4,500,000
  • Novel therapies for osteosarcoma (Richard Gorlick, M.D., Pediatrics) – $4,498,684

CPRIT Scholar Recruitment Awards:

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives